SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-036986
Filing Date
2018-06-11
Accepted
2018-06-11 16:39:12
Documents
2
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4203
2 POA DOCUMENT poa.txt EX-24.4_795750 3547
  Complete submission text file 0001209191-18-036986.txt   9154
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 284 WALTHAM MA 02451
Business Address
Laghrissi-Thode Fouzia (Reporting) CIK: 0001642015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 18892454